McCollister, Kathryn E.
Yang, Xuan
Murphy, Sean M.
Leff, Jared A.
Kronmal, Richard A.
Crane, Heidi M.
Chandler, Redonna K.
Taxman, Faye S.
Feaster, Daniel J.
Metsch, Lisa R.
Cunningham, William E.
Altice, Frederick L.
Schackman, Bruce R.
Funding for this research was provided by:
National Institute on Drug Abuse (P30DA040500, R21DA044378)
Article History
Received: 23 February 2018
Accepted: 29 August 2018
First Online: 21 September 2018
Ethics approval and consent to participate
: The participant data are completely deidentified and there is no way for us to link these data back to the individuals. In addition, the research is not focusing on individual-level analyses, rather we are looking in a more aggregate way at specific outcome domains and measures that can be used for economic analysis. This study does not represent human subjects research and did not require IRB approval.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.